Professional Documents
Culture Documents
TB Meninge
TB Meninge
TB Meninge
A Case of TB Meningitis
Roxanne Jeen L. Fornolles, M.D.
GENERAL OBJECTIVE
To present a case of TB Meningitis in a 17-year-old
patient presenting with headache, fever and vomiting.
SPECIFIC OBJECTIVES
• To identify the differential diagnoses of TB Meningitis.
• To discuss the epidemiology, pathogenesis, clinical
manifestations and current key strategies in the
diagnosis and management of TB Meningitis.
General Data
CD
17 yr old
Female
Roman Catholic
Headache
Fever
Vomiting
Prenatal, Natal, Postnatal History
Unremarkable
BCG 1 dose
OPV 3 doses
DPT 3 doses
Hepatitis B 3 doses
AMV 1 dose
MMR 1 dose
Past Medical History
Unremarkable
No history of trauma
Non-asthmatic
Non-hypertensive
7 months PTA
• One episode of left sided 2 weeks PTA
headache • Recurrence of Left-sided headache
• Throbbing • Vomiting
• Pain score of 5/10 • Diagnosed with Migraine headache
• numbness at the right • Tramadol plus Paracetamol given
side of the face • CT Scan was advised but unable to
•Paracetamol⇨relief. comply.
4 months PTA
• On and Off headache for 3
days
• Throbbing
• Numbness, right side of the
face.
HISTORY OF PRESENT ILLNESS
1-week PTA
• Generalized tonic seizure lasting
for less than 3 minutes.
3 days PTA
• One episode of fever Tmax of 38 C
• Headache with pain score of 8/10
• Brought to Bantayan Island District
Hospital
• Admitted for 2 days and started
Ceftriaxone; advised to transfer for
further management.
Physical Examination
General:
• Awake, oriented to person, place and time,
irritable, not in respiratory distress
Vital signs:
• Temp 39.4, PR 77bpm, RR 18cpm, BP 100/62,
Weight 60 kg, Height 157 cm, BMI 24.3 kg/m2
Physical Examination
Physical Examination
Skin
• Warm, no lesions, good turgor
HEENT:
• Normocephalic, Pink palpebral conjunctivae, pink and moist lips,
no lymphadenopathies
Abdomen:
• soft, nontender, Normoactive Bowel Sounds, no organomegaly
Extremities
• warm, strong peripheral pulses, CRT less than 2secs
Tanner Stage
• 5
Neuro Exam
Mental status
• Awake, conscious, irritable,
oriented to person, place and
time, speech is clear and
fluent with normal
comprehension.
• Combative and disoriented. GCS 15: E4 V5 M6⇨ GCS 14 CN I- not tested CN II- intact, full visual fields
Female
Headache
Fever
Seizure
Change in sensorium
TO CONSIDER
SPACE OCCUPYING LESION
PROBABLY BRAIN TUMOR
Differential Diagnoses
BRAIN TUMOR
Age ✔
Headache ✔
Nausea and vomiting ✔
Febrile episodes ✔/-
Seizure ✔
Change in sensorium ✔
Exposure to PTB -
Differential Diagnoses
CNS INFECTION
Viral Meningoencephalitis Bacterial TB
Meningoencephalitis Meningitis
Age ✔ ✔ ✔
Headache ✔ ✔ ✔
Nausea and ✔ ✔ ✔
Vomiting
Febrile episodes ✔ ✔ ✔
Seizure ✔ ✔ ✔
Change in ✔ ✔ ✔
sensorium
Exposure to TB - - ✔
Laboratory
Tests done at the ER
CBC TESTS Normal Patient
Normal Patient
Hemoglobin 11-16 12.2 Sodium 137-145 139
Hematocrit 31-46% 35.8%
MCV 80-100 92.3 Potassium 3.5-5.1 4.2
Platelet Count 140-440 387
WBC 5-10 8.56 Creatinine 0.7-1.2 0.6
Differential
count SGPT <35 20.09
Neutrophils 45-65 76
Lymphocytes 20-40 18
Monocytes 2-9 5
Eosinophils 0-6 1
Basophils 0-2 0
Laboratory
Tests done at the ER
Hospital Labs:
CBC:
Hgb: 12.8
Hct : 37.6
Impression:
Diffuse leptomeningeal enhancement compatible with leptomeningitis. Restricted
diffusion in the medial aspect of both temporal lobes, more on the left side which
may be seen in hyperacute infarcts, post-ictal changes in Herpes Simplex
encephalitis
Lumbar Tap
Normal Patient
CSF Cell count and differential count
Color
Day
Colorless
1-2
Volume 2.5 ml
Transparency Clear
Viscosity Non-viscous
Coagulum W/O Coagulum
WBC 781/cumm H
Segmenters 76%
Lymphocytes 24%
RBC 40/cumm
Normal <28 <5, >= 75 % lymph 20-45 >50 (or 75% serum glucose
In neonates: <20
Acute Bacterial meningitis Usually elevated 100-10,000 or more; Usually 100-500 Decreased, usually <40 (or
usually 300-2,000; PMNs <50% of serum glucose)
predominate
Viral meningoencephalitis Normal or slightly Rarely >1,000 cells. PMNs Usually 50-200 Generally normal, may be
elevated early but mononuclear decreased to <40 in some
cells predominate through viral diseases, particularly
most of the course mumps (15-20% of cases)
TB Meningitis Usually elevated 10-500; PMNs early, but 100-3,000; may be higher <50 in most cases;
lymphocytes predominate in the presence of block decreases with time if
through most of the course treatment is not provided
Fungal meningitis Usually elevated 5-500; PMNs early, but 25-500 <50; decreases with time if
lymphocytes predominate treatment is not provided.
through most of the
course. Cryptococcal
meningitis may lack
pleocytosis. Coccidiodal
meningitis may have
eosinophilia
Meningitis-Encephalitis Panel
Bacteria Viruses
E. Coli K1 Not detected Cytomegalovirus Not detected
H. Influenzae Not detected Enterovirus Not detected
L. monocytogenes Not detected HSV1 Not detected
N. Meningitidis Not detected HSV2 Not detected
S. agalactiae Not detected HHV6 Not detected
Day 1-2
S. pneumonia Not detected Human parechovirus
Varicella Zoster Virus
Not detected
Not detected
Yeast
Cryptococcus neoformans/gratii Not detected
XPERT MTB/RIF
MTB HAS NOT BEEN DETECTED
AFB STAINING: 0
Hospital
Day 1-2
EEG
Abnormal showing generalized slowing of the background activity suggestive of a nonspecific
encephalopathic process
S
Awake, irritable,
O
VS: T 38.5, PR 70, RR 26 , BP 120/80
A
TB Meningitis
Day 3-4
P
Referred to PIDS
combative, oriented to CN II-Left medial Rectus Palsy PCAP-C Continued on
person only CN II, IV, VI- Right eye: pupil 4mm and reactive to Ceftriaxone
Headache with PS of light, brisk, full EOM Started on:
9/10. Febrile episodes. Left eye: pupil 5mm, sluggish reaction, (+) ptosis Pyrazinamide
Had onset of focal right CN V- Right eye: (+) corneal reflex. Left eye: (-) 400mg+ Rifampicin
sided tonic seizure corneal reflex 150 mg+ INH 75
lasting for 4 seconds. CN VII- No facial asymmetry mg+ Ethambutol
Motor strength: Right sided Hemiparesis 275 mg tab 4 tabs /
Febrile episodes still noted. VS: T 38, PR 78, RR 21, BP 110/80 TB Meningitis
Day 5
Mannitol 0.3 g/k q6H
Generalized tonic Seizure S-GCS 10 (E2V2M6) PCAP-C Valproic acid
persisted lasting for 3-4 P- Right eye: pupil 2mm and reactive to increased to 17mkD
seconds. light, brisk, full EOM. Left eye: pupil 3mm, Started on:
Stuporous; partial eye sluggish reaction, (+) ptosis Citicoline 500mg Q8H
opening to pain E- Full EOM on Right eye, Left medial Esomeprazole 40mg
rectus palsy IVTT OD
R- spontaneous O2 @ 2lpm
M: Right sided Hemiparesis NGT inserted and
Hospital Labs:
started on feeding
q3H
FBC inserted
day 5 CBC
Hgb 11.5
Hct 33.7
HGT monitoring
UO and neuro VS
monitored q hourly
WBC 9.46
Plt317
Neu 76, Lymph15, Mono 9, Eos 0 Baso 0
Na: 138 K: 3.4
Cranial CT Scan:
• Fairly defined foci of hypodensities noted in the medial aspect of both temporal lobes
corresponding to the areas of restricted diffusion seen in the previous MRI study.
• A focus of hypodensity is now appreciated in the genu of the internal capsule.
• The ventricles are normal in size and configuration.
Impression:
• Evolving infarcts to subacute phase, medial aspect of both temporal lobes. New acute
infarct, genu of the left internal capsule.
S O A P
Day 5
Febrile episodes still noted. VS: T 38, PR 78, RR 21, BP 110/80 TB Meningitis Mannitol 0.3 g/k q6H
Generalized tonic Seizure S-GCS 10 (E2V2M6) PCAP-C Valproic acid
persisted lasting for 3-4 P- Right eye: pupil 2mm and reactive to increased to 17mkD
seconds. light, brisk, full EOM. Left eye: pupil 3mm, Started on:
Stuporous; partial eye sluggish reaction, (+) ptosis Citicoline 500mg Q8H
opening to pain E- Full EOM on Right eye, Left medial Esomeprazole 40mg
rectus palsy IVTT OD
R- spontaneous O2 @ 2lpm
Hospital M: Right sided Hemiparesis NGT inserted and
started on feeding
q3H
day 5 Labs:
CBC
Hgb 11.5
FBC inserted
HGT monitoring
UO and neuro VS
Hct 33.7 monitored q hourly
WBC 9.46
Plt317
Neu 76, Lymph15, Mono 9, Eos 0 Baso 0
Na: 138 K: 3.4
S O A P
Febrile episodes still noted. VS: T 38.1, PR 51, RR 21, BP 120/90 TB Meningitis
Day 6-11
Ceftriaxone day 6
No recurrence of seizures. P/E: HEENT: + Blister on left upper lip PCAP-C completed and shifted to
Lethargic----- awake S-GCS 13 (E4V4M5) Meropenem
P- Right eye: pupil 2mm and reactive Mannitol decreased to
to light, brisk, full EOM. Left eye: pupil 60ml q8h
3mm, sluggish reaction, (+) ptosis Rowagel oral gel applied on
E- Full EOM on Right eye, Left medial lesion QID
rectus palsy O2 inhalation shifted to
R- spontaneous PRN
M: Right sided Hemiparesis Ibuprofen--- Hold
S O A P
16 Hgb 13
Hct 38
WBC 13.45
Referred to
Rehab Medicine
for PT
Plt 372 Encouraged to
Neu 79, Lymph 15, Mono 6, Eos 0, Baso 0 sit-up in bed
Serum Na: 139 Serum K: 4.1 CRP: 2.37
S O A P
21
S O A P
Hospital
commands S-GCS 13 (E4V4M5)
P- Right eye: pupil 2mm and reactive to
light, brisk, full EOM. Left eye: pupil
Citicoline 500mg BID
Paracetamol
ORS
3mm, sluggish reaction, (+) ptosis Zinc Sulfate
Day 22- E- Full EOM on Right eye, Left medial
rectus palsy
R- spontaneous
TB Meningitis
PPS Registry
January 2019-September 2020
2%
Total: 393 cases
18%
81%
Infarcts
Infiltration cerebral Vascular stenosis,
vessel wall occlusion, spasm Decreased
Cerebral Blood
Flow
Exudate Hydrocephalus Mortality
Tuberculoma or
Containment of
Tuberculous
Bacilli
abscesses Disease
resolution
Extension of disease Spinal
into spinal canal arachnoiditis,
tuberculomas,
exudate
Clinical Manifestations
Onset is gradual occurring over a period of
approximately 3 weeks.
SECOND STAGE: signs of
increased ICP and cerebral
FIRST STAGE: personality damage: drowsiness, stiff THIRD STAGE: coma,
changes, listlessness, neck, CN palsies, irregular pulse and
irritability, anorexia and inequality of the pupils, respirations and rising
some fever. vomiting, tache cerebrale, fever.
absence of abdominal
reflexes, and convulsions
Diagnostic Work-up
In many cases, by the time meningitis develops, the original focus in the
lungs may no longer be demonstrable by plain radiographic studies.
CSF sample should be sent for acid fast smear but a single sample has low
sensitivity, 20-40%.
CSF Culture also has low sensitivity and can take several weeks for the
result.
Diagnostic Work-up
Rifampicin Isoniazid
Pyrazinamide Ethmabutol
Source: TB (DS and DR) and Latent TB Screening, Diagnoses and Management page 16
Source: TB (DS and DR) and Latent TB Screening, Diagnoses and Management page 17
Source: TB (DS and DR) and Latent TB Screening, Diagnoses and Management page 18
Source: TB (DS and DR) and Latent TB Screening, Diagnoses
and Management page 19
Source: TB (DS and DR) and Latent TB Screening, Diagnoses and
Management page 20
4 Random Clinical trials
13 prospective cohort studies
1 unpublished ongoing cohort study
Management